Contact
Please use this form to send email to PR contact of this press release:
Sequence LifeScience Inc Receives IRB Approval for Novel Matched Controls Clinical Trial Targeting Diabetic Foot Ulcers
TO:
Stephanie Lopez
Sequence LifeScience
+1 210-545-3713